The human apolipoprotein E (APOE) gene contains several single-nucleotide polymorphisms (SNPs) that are distributed across the gene [1] . The 2 most common SNPs lead to changes in the coding sequence and yield 3 different polymorphic alleles which engender 6 different genotypes: ε 2, ε 3, and ε 4, ( Table 1 ). In addition, rare alleles such as ε 1, ε 5, ε 7, etc., are also present. In contrast to the ε 3 allele, the ε 2 allele is associated with protection against late-onset Alzheimer' s disease (AD) [2] . Most patients with type III hyperlipoproteinemia are also known to be homozygous for the ε 2 allele [3] . However, the presence of the ε 4 allele is a risk factor for AD and is associated with early onset of AD [2, [4] [5] [6] . Thus, the genotypes of the APOE gene have important implications as risk factors for AD, cardiovascular disease, etc.
Korea) and FRET (LightCycler ApoE Mutation Detection
Kit; Roche Diagnostics, Mannheim, Germany). Further, 102 subjects (group 2) underwent genotyping with AS-PCR along with sequencing analysis of 4 exons of APOE.
For the remaining 531 subjects (group 3), sequencing analysis was performed to confirm the presence of homozygous ε 2 alleles, which was predicted by the results of previously performed AS-PCR.
One subject (case 1) from group 1 was shown to have the genotype ε 2/ε 2 and ε 2/ε 3 by AS-PCR and FRET, respectively. A sequencing analysis of this case showed that the subject had the genotype ε 2/ε 3 with 2 single-nucleotide G-to-A substitutions at the nucleotide positions 784 and 787, which both lead to the substitution of glutamic acid (GLU) to lysine (LYS) residue. In group 2, the results obtained using AS-PCR and sequencing analysis of 4 APOE exons were similar, and one of the ε 3 homozygous alleles had the SNP. In group 3, 5 of the 531 cases were identified as ε 2/ε 2 by AS-PCR; among these, one subject (case 2) was identified as ε 2/ε 3 with SNP and 4 were identified as ε 2/ε 2. AS-PCR and sequencing analysis results of the two cases are shown in Fig. 2, 3 , respectively. Case 2 with no band for 526C. As a result of this phenomenon, ε 3/ε 7, ε 4/ε 7, and ε 2/ε 7 were interpreted as ε 3/ε 3, ε 4/ε 3, and ε 2/ε 2, respectively, in AS-PCR (Fig. 4) .
The ε 7 allele is associated with hyperlipidemia and atherosclerosis, and the APOE protein of this allele shows defects in its binding to the LDL receptor [12] . However, in a study conducted using the recombinant allele ε 7 of APOE, Dong et al. [13] reported that the receptor-binding activity is not affected. Therefore, the association between ε 7 and LDL receptor-binding activity is unclear.
According to our data for group 2, in which sequencing of the entire APOE gene was performed, the relative frequency of the ε 7 allele was 0.0049, and this was less than that of the ε 2 allele (0.0833). Information about other rare alleles, including ε 7, has been reported; however, this information is less important than that for the common alleles, such as ε 2, ε 3, and ε 4.
In summary, sequencing analysis showed errors in genotyping when AS-PCR using the ApoE Genotyping Kit was performed. Moreover, we determined that the ε 2 homozygous result requires further evaluation by sequencing analysis or other methods by using primers that can avoid the error caused by unexpected nucleotide polymorphisms or mutations located in the DNA template. Fig. 4 . PCR bands of each allele (ε 2, ε 3, ε 4, and ε 7) and their interpretations in AS-PCR. The ε 7 alleles of genotypes ε 3/ε 7 and ε 4/ε 7 were interpreted as ε 3, and the ε 7 allele of genotype ε 2/ε 7 was interpreted as ε 2 (dotted box). ε 2 ε 3 ε 4 ε 7 ε 2/ε 3 ε 2/ε 4 ε 2/ε 7 ε 3/ε 4ε ε 3/ε 7 ε 4/ε 7 ε 7/ε 7 (=ε 2/ε 2) (=ε 3/ε 3) (=ε 4/ε 3) 779 bp (IC) 518 bp (526T) 447 bp (388C) 376 bp (388T) 311 bp (526C)
